World Leukaemia Day 2020

Latest from the Blog

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more
DRE and Prostate Cancer

DRE and Prostate Cancer

Friday 27th March 2020 A digital rectal examination (DRE) is a useful screening tool, which can be used in conjunction with a PSA test, to help determine if a patient should be referred on a prostate cancer pathway. Prostate cancers may not necessarily secrete PSA;...

read more

Related Posts

Friday 4th September 2020

It’s World Leukaemia Day today.

Are you confident in spotting the early signs of Leukaemia?

Why not brush up on your knowledge and complete our free online Acute Leukaemia – Early Diagnosis and Chronic Leukaemia – Early Diagnosis courses created in collaboration with Leukaemia Care?

Acute leukaemia can progress rapidly, usually requiring immediate treatment. The two most common types of acute leukaemia are acute myeloid leukaemia (AML), most often diagnosed in older people, and acute lymphoblastic leukaemia (ALL) most often diagnosed in younger people.

Both chronic lymphocytic leukaemia (CLL) and chronic myeloid leukaemia (CML) are often picked up incidentally in primary care. This is because presentation of these diseases can be gradual, with most patients with CLL diagnosed after undergoing a routine blood test.

Our courses will support you to:

  • Increase your awareness of the symptoms and diagnosis of acute and chronic leukaemia
  • Understand  the different presentations, referral and management of acute and chronic leukaemia
  • Confidently assess the need for urgent referrals in accordance with the NICE NG12 guidelines
  • Appropriately safety net patients
  • Increase your confidence in dealing with angry patients

Find out more:

  • Access GatewayC’s Acute Leukaemia – Early Diagnosis course here
  • Access GatewayC’s Chronic Leukaemia – Early Diagnosis course here
  • Read our Cancer Key on Leukaemia and FBCs here
  • Read our Cancer Key on Chronic Myeloid Leukaemia and Fatigue here
  • Find out more about World Leukaemia Day here
  • Learn about Leukaemia Care’s Spot Leukaemia campaign here

Follow us: LinkedIn | Twitter | Facebook

Latest from the Blog

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more
DRE and Prostate Cancer

DRE and Prostate Cancer

Friday 27th March 2020 A digital rectal examination (DRE) is a useful screening tool, which can be used in conjunction with a PSA test, to help determine if a patient should be referred on a prostate cancer pathway. Prostate cancers may not necessarily secrete PSA;...

read more

Related Posts